NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
11.15
-0.11 (-0.93%)
Apr 25, 2025, 4:00 PM EDT - Market closed
NeuroPace Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for NeuroPace stock have an average target of 14.83, with a low estimate of 8.00 and a high estimate of 20. The average target predicts an increase of 33.06% from the current stock price of 11.15.
Analyst Consensus: Buy
* Price targets were last updated on Mar 5, 2025.
Analyst Ratings
The average analyst rating for NeuroPace stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +79.45% | Mar 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $13 → $17 | Buy | Maintains | $13 → $17 | +52.53% | Jan 30, 2025 |
| UBS | UBS | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +52.53% | Jan 21, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $9 → $14 | Buy | Maintains | $9 → $14 | +25.62% | Dec 17, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $15 → $13 | Buy | Maintains | $15 → $13 | +16.64% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
95.51M
from 79.91M
Increased by 19.53%
Revenue Next Year
106.81M
from 95.51M
Increased by 11.83%
EPS This Year
-0.87
from -0.93
EPS Next Year
-0.58
from -0.87
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 100.8M | 119.7M | 147.4M | ||
| Avg | 95.5M | 106.8M | 134.7M | ||
| Low | 90.2M | 96.0M | 118.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.2% | 25.3% | 38.0% | ||
| Avg | 19.5% | 11.8% | 26.1% | ||
| Low | 12.8% | 0.6% | 10.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.57 | -0.21 | -0.12 | ||
| Avg | -0.87 | -0.58 | -0.33 | ||
| Low | -0.94 | -0.82 | -0.60 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.